On February 8 - 9 2017, the Disrupting Clinical Trials Europe Conference in Kensington will bring together innovators in the clinical trial space. The Conference aims to introduce new, bold approaches to help attendees think differently about how they do clinical trials and present global examples of those pushing the clinical trial envelope.

Led by Co-Chairs Dr Sue Collier (GSK) and Dr Jeff Kasher (Patients Can’t Wait), the program presents global case studies on:

  • Real World Clinical Trial Strategies and Results
  • New Leadership in Driving Clinical Trial Innovation
  • Strategies to Validate the Siteless Trial
  • Community Outreach and Education in Clinical Trials
  • New Financial Models
  • Patient Involvement and Engagement
  • Brexit Update and Potential Impact on R&D
  • Protocol Simulation
  • Adaptive Trial Model

With support from MedCity, the British Consulate and NIHR Clinical Research Network, we look forward to bringing more global examples of disrupting clinical trials and to collaborating on an even broader scale between industry and others.

Highlights for 2017 include:

  • Making History: the results of crowdfunding the first clinical trial and the possibilities for the future of drug development
  • Real World Data Strategy and Results to disrupt clinical trials
  • New European leadership from big pharma disrupting clinical research
  • Community collaborating with industry to disrupt clinical trials

Friends of MedCity receive a 20% discount using code: MCITY20

For more information and to register for the Conference at the Millennium Gloucester Hotel, London visit: http://theconferenceforum.org/conferences/dpharm-europe/overview/